A Part 2 program (federally regulated substance use disorder treatment program) or other lawful holder may report SUD medications prescribed or dispensed to a state prescription drug monitoring program (PDMP) when required by state law, but must first obtain patient consent under 42 CFR § 2.31 before making such a disclosure. This rule governs the conditions and consent requirements for PDMP reporting by Part 2 programs.
View official source§ 2.36 Disclosures to prescription drug monitoring programs. A part 2 program or other lawful holder is permitted to report any SUD medication prescribed or dispensed by the part 2 program to the applicable state prescription drug monitoring program if required by applicable state law. A part 2 program or other lawful holder must obtain patient consent to a disclosure of records to a prescription drug monitoring program under § 2.31 prior to reporting of such information. [85 FR 43038, July 15, 2020]